• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年人流感和肺炎球菌疫苗接种的临床实践与公共政策

Clinical practice and public policy for influenza and pneumococcal vaccination of the elderly.

作者信息

Fedson D S

机构信息

Department of Medicine, University of Virginia School of Medicine, Charlottesville.

出版信息

Clin Geriatr Med. 1992 Feb;8(1):183-99.

PMID:1576575
Abstract

Influenza and pneumococcal vaccines are safe, effective, and cost-effective, but they are not used widely. Organized programs for vaccine delivery can lead to substantial improvements in vaccination rates for the elderly. Adequate reimbursement by Medicare and other third-party payers needs to be supplemented by educational programs to promote influenza and pneumococcal vaccines if the opportunity vaccination presents to improve the health and well-being of elderly persons is to be fully realized.

摘要

流感疫苗和肺炎球菌疫苗安全、有效且具有成本效益,但它们的使用并不广泛。有组织的疫苗接种计划可大幅提高老年人的疫苗接种率。如果要充分实现通过接种疫苗改善老年人健康和福祉的机会,医疗保险和其他第三方支付者的充分报销还需辅以教育计划来推广流感疫苗和肺炎球菌疫苗。

相似文献

1
Clinical practice and public policy for influenza and pneumococcal vaccination of the elderly.老年人流感和肺炎球菌疫苗接种的临床实践与公共政策
Clin Geriatr Med. 1992 Feb;8(1):183-99.
2
Prevention of respiratory infections in adults. Influenza and pneumococcal vaccines.成人呼吸道感染的预防。流感疫苗和肺炎球菌疫苗。
Arch Intern Med. 1994 Nov 28;154(22):2545-57.
3
Missed opportunities for pneumococcal and influenza vaccination of Medicare pneumonia inpatients--12 western states, 1995.1995年12个西部州医疗保险肺炎住院患者肺炎球菌和流感疫苗接种的错失机会
MMWR Morb Mortal Wkly Rep. 1997 Oct 3;46(39):919-23.
4
Pneumococcal and influenza vaccination levels among adults aged > or = 65 years--United States, 1995.1995年美国65岁及以上成年人的肺炎球菌和流感疫苗接种率
MMWR Morb Mortal Wkly Rep. 1997 Oct 3;46(39):913-9.
5
Influenza and pneumococcal vaccination levels among adults aged > or =65 years--United States, 1997.美国1997年65岁及以上成年人的流感和肺炎球菌疫苗接种率
MMWR Morb Mortal Wkly Rep. 1998 Oct 2;47(38):797-802.
6
Pneumococcal and influenza vaccination levels among adults aged > or = 65 years--United States, 1993.1993年美国65岁及以上成年人的肺炎球菌和流感疫苗接种率
MMWR Morb Mortal Wkly Rep. 1996 Oct 11;45(40):853-9.
7
Differences in attitudes, beliefs and knowledge of hospital health care workers and community doctors to vaccination of older people.医院医护人员和社区医生在对待老年人接种疫苗的态度、信念和知识方面的差异。
Vaccine. 2008 Oct 16;26(44):5633-40. doi: 10.1016/j.vaccine.2008.07.070. Epub 2008 Aug 14.
8
Influenza and pneumococcal vaccination of the elderly: newer vaccines and prospects for clinical benefits at the margin.老年人的流感和肺炎球菌疫苗接种:新型疫苗及边际临床获益前景
Prev Med. 1994 Sep;23(5):751-5. doi: 10.1006/pmed.1994.1129.
9
Reasons reported by Medicare beneficiaries for not receiving influenza and pneumococcal vaccinations--United States, 1996.1996年美国医疗保险受益人报告的未接种流感和肺炎球菌疫苗的原因
MMWR Morb Mortal Wkly Rep. 1999 Oct 8;48(39):886-90.
10
Influenza and pneumococcal vaccination rates among persons with diabetes mellitus--United States, 1997.1997年美国糖尿病患者的流感和肺炎球菌疫苗接种率
MMWR Morb Mortal Wkly Rep. 1999 Oct 29;48(42):961-7.

引用本文的文献

1
Improving surveillance of the impact of influenza and its prevention in Canada.加强加拿大流感影响及其预防的监测。
Can J Infect Dis. 1993 Sep;4(5):257-62. doi: 10.1155/1993/562460.
2
Efficacy of influenza vaccine among elderly patients by physical activity status.流感疫苗对体力活动状况不同的老年患者的疗效。
Environ Health Prev Med. 2002 Nov;7(5):183-8. doi: 10.1007/BF02898002.
3
Targeting pneumococcal vaccination to high-risk groups: a feasibility study in one general practice.针对高危人群的肺炎球菌疫苗接种:一项全科医疗实践中的可行性研究。
Postgrad Med J. 1999 Apr;75(882):208-12. doi: 10.1136/pgmj.75.882.208.
4
The cost effectiveness of pneumococcal vaccination strategies.肺炎球菌疫苗接种策略的成本效益
Pharmacoeconomics. 1997 Aug;12(2 Pt 1):161-74. doi: 10.2165/00019053-199712020-00006.
5
Economic evaluation of influenza vaccination and economic modelling. Can results be pooled?
Pharmacoeconomics. 1996;9 Suppl 3:67-72. doi: 10.2165/00019053-199600093-00015.
6
Evaluating the impact of influenza vaccination. A North American perspective.评估流感疫苗接种的影响。北美视角。
Pharmacoeconomics. 1996;9 Suppl 3:54-61. doi: 10.2165/00019053-199600093-00013.
7
Removing barriers to vaccination use by older adults.消除老年人接种疫苗的障碍。
Drugs Aging. 1994 May;4(5):357-65. doi: 10.2165/00002512-199404050-00001.
8
Attitudes and behavior of health care personnel regarding influenza vaccination.医护人员对流感疫苗接种的态度和行为。
Eur J Epidemiol. 1994 Feb;10(1):63-8. doi: 10.1007/BF01717454.
9
Influenza vaccination in older patients. Immunogenicity, epidemiology and available agents.老年患者的流感疫苗接种。免疫原性、流行病学及可用制剂。
Drugs Aging. 1995 May;6(5):368-87. doi: 10.2165/00002512-199506050-00004.